Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial

Clinical Microbiology and Infection

Volumn 23, Issue 3, 2017, Pages 173-178

  Santolaya, M E ^a,c   Alvarez, A M ^a,c   Acuna M ^a,c   Aviles C L ^a,c   Salgado, C ^b,c   Tordecilla, J ^a,c   Varas, M ^a,c   Venegas, M ^a   Villarroel, M ^a,c   Zubieta, M ^b,c   Toso, A ^a   Bataszew, A ^a   Farfan M J ^a   de la Maza, V ^a   Vergara, A ^a   Valenzuela, R ^a   Torres, J P ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Pediatra Reumatólogo Unidad Inmuno Reumatología Hospital Dr Exequiel González Cortés   (Chile)

^c Subcommittee of Infectious Diseases   (Chile)

Author keywords

Antimicrobials; Cancer; Children; Febrile neutropenia; Respiratory viral infection

Indexed keywords

AMIKACIN; CEFTAZIDIME; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ADENOVIRIDAE; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CHILD; CHILD HOSPITALIZATION; CHILDHOOD CANCER; CHILE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONAVIRIDAE; DRUG WITHDRAWAL; ENTEROVIRUS B; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN BOCAVIRUS; HUMAN METAPNEUMOVIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS A; INFLUENZA A; INFLUENZA B; INFLUENZA C; LABORATORY TEST; LENGTH OF STAY; LEUKEMIA; LEUKEMIA RELAPSE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MULTICENTER STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; OUTCOME ASSESSMENT; PEDIATRIC INTENSIVE CARE UNIT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; RISK BENEFIT ANALYSIS; SAFETY; SEPSIS; SOLID TUMOR; TREATMENT DURATION; TREATMENT WITHDRAWAL; VIRAL RESPIRATORY TRACT INFECTION; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; HOSPITAL; INFANT; NEOPLASM; NEWBORN; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; VIRUS DISEASES;

ADOLESCENT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CHILE; FEBRILE NEUTROPENIA; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; VIRUS DISEASES; WITHHOLDING TREATMENT;

EID: 85008199871     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.11.001     Document Type: Article

References (30)

1. [1] Lehrnbecher, T., Phillips, R., Alexander, S., Alvaro, F., Carlesse, F., Fisher, B., et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 30 (2012), 4427–4438.
2. [2] Hagag, A.A., Hassan, S.M., Elgamasy, M.A., Afifi, I.K., Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study. Infect Disord Drug Targets 16 (2016), 54–62.
3. [3] Barton, C.D., Waugh, L.K., Nielsen, M.J., Paulus, S., Febrile neutropenia in children treated for malignancy. J Infect 71:Suppl. 1 (2015), S27–S35.
4. [4] Santolaya, M.E., Supportive care in children. Curr Opin Oncol 22 (2010), 323–329.
5. [5] Hughes, W.T., Armstrong, D., Bodey, G.P., Bow, E.J., Brown, A.E., Calandra, T., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002), 730–751.
6. [6] Torres, J.P., Labrana, Y., Ibanez, C., Kasaneva, P., Farfan, M.J., De la Maza, V., et al. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia. Pediatr Infect Dis J 31 (2012), 889–893.
7. [7] Benites, E.C., Cabrini, D.P., Silva, A.C., Silva, J.C., Catalan, D.T., Berezin, E.N., et al. Acute respiratory viral infections in pediatric cancer patients undergoing chemotherapy. J Pediatr (Rio J) 90 (2014), 370–376.
8. [8] Fukutani, K.F., Nascimento-Carvalho, C.M., Van der Gucht, W., Wollants, E., Khouri, R., Dierckx, T., et al. Pathogen transcriptional profile in nasopharyngeal aspirates of children with acute respiratory tract infection. J Clin Virol 69 (2015), 190–196.
9. [9] Meissner, H.C., Viral Bronchiolitis in Children. N Engl J Med 374 (2016), 62–72.
10. [10] Christensen, M.S., Nielsen, L.P., Hasle, H., Few but severe viral infections in children with cancer: a prospective RT-PCR and PCR-based 12-month study. Pediatr Blood Cancer 45 (2005), 945–951.
11. [11] Koskenvuo, M., Mottonen, M., Rahiala, J., Saarinen-Pihkala, U.M., Riikonen, P., Waris, M., et al. Respiratory viral infections in children with leukemia. Pediatr Infect Dis J 27 (2008), 974–980.
12. [12] Lindblom, A., Bhadri, V., Soderhall, S., Ohrmalm, L., Wong, M., Norbeck, O., et al. Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol 47 (2010), 234–237.
13. [13] Mendoza Sanchez, M.C., Ruiz-Contreras, J., Vivanco, J.L., Fernandez-Carrion, F., Baro Fernandez, M., Ramos, J.T., et al. Respiratory virus infections in children with cancer or HIV infection. J Pediatr Hematol Oncol 28 (2006), 154–159.
14. [14] Martinez, P., Cordero, J., Valverde, C., Unanue, N., Dalmazzo, R., Piemonte, P., et al. Viral respiratory co-infections in pediatric patients admitted for acute respiratory infection and their impact on clinical severity. Rev Chilena Infectol 29 (2012), 169–174.
15. [15] Wong-Chew, R.M., Espinoza, M.A., Taboada, B., Aponte, F.E., Arias-Ortiz, M.A., Monge-Martinez, J., et al. Prevalence of respiratory virus in symptomatic children in private physician office settings in five communities of the state of Veracruz, Mexico. BMC Res Notes, 8, 2015, 261.
16. [16] Santolaya, M.E., Alvarez, A.M., Becker, A., Cofre, J., Enriquez, N., O'Ryan, M., et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19 (2001), 3415–3421.
17. [17] Santolaya, M.E., Alvarez, A.M., Aviles, C.L., Becker, A., Cofre, J., Enriquez, N., et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 35 (2002), 678–683.
18. [18] Miedema, K.G., Tissing, W.J., Abbink, F.C., Ball, L.M., Michiels, E.M., van Vliet, M.J., et al. Risk-adapted approach for fever and neutropenia in paediatric cancer patients—a national multicentre study. Eur J Cancer 53 (2016), 16–24.
19. [19] Spasova, M.I., Grudeva-Popova, J.G., Kostyanev, S.S., Genev, E.D., Stoyanova, A.A., Kirina, V.I., et al. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies. J BUON 14 (2009), 411–418.
20. [20] Villarroel, M., Aviles, C.L., Silva, P., Guzman, A.M., Poggi, H., Alvarez, A.M., et al. Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation. Pediatr Infect Dis J 29 (2010), 816–821.
21. [21] Ozsevik, S.N., Sensoy, G., Karli, A., Albayrak, C., Dagdemir, A., Belet, N., et al. Invasive fungal infections in children with hematologic and malignant diseases. J Pediatr Hematol Oncol 37 (2015), e69–e72.
22. [22] Santolaya, M.E., Alvarez, A.M., Aviles, C.L., Becker, A., Venegas, M., ÓRyan, M., et al. Prospective validation of a risk prediction model for severe sepsis in children with cancer and high risk fever and neutropenia. Pediatr Infect Dis J 32 (2013), 1318–1323.
23. [23] Rondinelli, P.I., Ribeiro Kde, C., de Camargo, B., A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol 28 (2006), 665–670.
24. [24] Santolaya, M.E., Farfan, M.J., De La Maza, V., Cocina, M., Santelices, F., Alvarez, A.M., et al. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach. Pediatr Infect Dis J 30 (2011), 957–961.
25. [25] Shachor-Meyouhas, Y., Sprecher, H., Moscoviz, D., Zaidman, I., Haimi, M., Kassis, I., Molecular-based diagnosis of bacteremia in the setting of fever with or without neutropenia in pediatric hematology-oncology patients. J Pediatr Hematol Oncol 35 (2013), 500–503.
26. [26] Santolaya, M.E., Alvarez, A.M., Aviles, C.L., Becker, A., Cofre, J., Cumsille, M.A., et al. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 22 (2004), 3784–3789.
27. [27] Paganini, H., Santolaya, M.E., Alvarez, M., Araña, M., Arteaga, R., Bonilla, A., et al. Diagnóstico y tratamiento de la neutropenia febril en niños con cáncer: Consenso de la Sociedad Latinoamericana de Infectología Pediátrica. Rev chil infectol 28:Suppl. 1 (2011), 10–38.
28. [28] Castagnola, E., Fontana, V., Caviglia, I., Caruso, S., Faraci, M., Fioredda, F., et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 45 (2007), 1296–1304.
29. [29] Babady, N.E., Mead, P., Stiles, J., Brennan, C., Li, H., Shuptar, S., et al. Comparison of the Luminex xTAG RVP Fast assay and the Idaho Technology FilmArray RP assay for detection of respiratory viruses in pediatric patients at a cancer hospital. J Clin Microbiol 50 (2012), 2282–2288.
30. [30] Jartti, T., Lehtinen, P., Vuorinen, T., Koskenvuo, M., Ruuskanen, O., Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 72 (2004), 695–699.